In the first half of 2025, European startups secured €19bn in funding, showcasing diverse investments across innovative sectors. Helsing led with €600M for AI defense systems, while Isomorphic Labs raised €508M to accelerate drug discovery using AI. NEoT obtained €350M to finance clean transport projects, emphasizing green infrastructure. Verdiva Bio raised €348M for novel drugs targeting obesity, illustrating strong investor demand in the biotech field. Other notable rounds included funding for AI-powered health technology and Bitcoin mining, reflecting emerging trends in various industries.
Helsing raised €600M for AI-powered defense systems, achieving a €12bn valuation, underscoring Europe's booming defense tech sector.
Isomorphic Labs, a DeepMind spinout, secured €508M to enhance drug discovery with AI, demonstrating investor confidence in reshaping pharma R&D.
NEoT raised €350M, focusing on financing clean transport and off-grid energy projects, essential for scaling Europe's green infrastructure.
Verdiva Bio's €348M funding marks one of Europe's largest biotech deals aimed at combating the obesity epidemic through innovative drug development.
Collection
[
|
...
]